![Gudmund Tyge Korsgaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gudmund Tyge Korsgaard
Directeur Général chez
Den Sociale Kapitalfond Invest I K/S
Profil
Gudmund Tyge Korsgaard is currently the Chief Executive Officer & Director at Den Sociale Kapitalfond Invest I K and the Chief Executive Officer at Tyge Korsgaard Consult ApS.
He is also the Chairman at Vivostat A and Vivostat Holding ApS, and a Director at Familien Skak Holding ApS, Gribskov Gruppen AS, Caissa Group ApS, and Fonden DSK Invest I GP.
In the past, he served as the Chairman at NsGene A, Director at CAPRES A, TD Vaccines A, and Pila Pharma AB, and Senior Investment Manager at MAJ Invest Equity A. He was also an Investment Manager at Fondsmæglerselskabet Maj Invest A. Korsgaard graduated from the University of Aalborg.
Postes actifs de Gudmund Tyge Korsgaard
| Sociétés | Poste | Début |
|---|---|---|
Vivostat A/S
 Vivostat A/S Medical SpecialtiesHealth Technology Manufactures and distributes systems for on-site preparation & application of autologous concentrated fibrin and platelet enriched fibrin sealants | Président | 01/01/2000 |
Vivostat Holding ApS | Président | - |
Den Sociale Kapitalfond Invest I K/S
 Den Sociale Kapitalfond Invest I K/S Investment ManagersFinance Acts as Venture Capital Fund | Directeur Général | - |
Familien Skak Holding ApS | Directeur/Membre du Conseil | - |
Caissa Group ApS
 Caissa Group ApS Miscellaneous Commercial ServicesCommercial Services Provides research design programs services | Directeur/Membre du Conseil | - |
Tyge Korsgaard Consult ApS | Directeur Général | - |
Fonden DSK Invest I GP | Directeur/Membre du Conseil | - |
Anciens postes connus de Gudmund Tyge Korsgaard
| Sociétés | Poste | Fin |
|---|---|---|
| PILA PHARMA AB | Directeur/Membre du Conseil | 07/06/2022 |
Gribskov Gruppen AS | Directeur/Membre du Conseil | 17/07/2021 |
| ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░ | ░░░░░░░░░░ | - |
Formation de Gudmund Tyge Korsgaard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
40
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
University of Aalborg
 University of Aalborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MAJ Invest Equity A/S
 MAJ Invest Equity A/S Investment ManagersFinance MAJ Invest is an active manager which provides equity funding for buyout transactions, such as MBOs, MBIs, and spin-offs. The firm invests in small and mid-sized companies with annual revenues between DKK 200 and 1.000 million located in Denmark. MAJ Invest invests in companies across a broad range of sectors and industries, and looks to take both minority and majority stake positions in its investments, as well as a seat on the board. | Finance |
Fondsmæglerselskabet Maj Invest A/S
 Fondsmæglerselskabet Maj Invest A/S Investment ManagersFinance Maj Invest offers a global value equity strategy and invests in a range of securities and asset classes from markets around the world. The strategy’s geographic focus is both securities of issuers from developing countries and securities of issuers from developed countries. Asset classes may include publicly- listed common and preferred equities, including ADRs, GDRs and EDRs. The strategy may invest in securities denominated in US dollars or in foreign currencies. This strategy does not invest in derivatives and other financial instruments. | Finance |
Vivostat A/S
Vivostat A/S Medical SpecialtiesHealth Technology Manufactures and distributes systems for on-site preparation & application of autologous concentrated fibrin and platelet enriched fibrin sealants | Health Technology |
CAPRES A/S
 CAPRES A/S Electronic Production EquipmentElectronic Technology Provides electrical characterization of materials technology for semiconductor industry | Electronic Technology |
TD Vaccines A/S
 TD Vaccines A/S Pharmaceuticals: MajorHealth Technology Provides vaccines to protect against travellers' diarrhoea | Health Technology |
Pila Pharma AB
 Pila Pharma AB BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company which develops oral anti-diabetic agents | Health Technology |
Den Sociale Kapitalfond Invest I K/S
Den Sociale Kapitalfond Invest I K/S Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Vivostat Holding ApS | |
Familien Skak Holding ApS | |
Gribskov Gruppen AS | |
Caissa Group ApS
Caissa Group ApS Miscellaneous Commercial ServicesCommercial Services Provides research design programs services | Commercial Services |
Tyge Korsgaard Consult ApS | |
Fonden DSK Invest I GP |
Choisissez Zonebourse 
